Trihexyphenidyl Hydrochloride NDC 63850-0022

NDC codes

FDA NDC Directory

Product NDC (as listed)63850-0022Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63850-0022Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63850-0022-1	63850002201	100 TABLET in 1 BOTTLE (63850-0022-1)Marketed from Oct 17, 2010
63850-0022-2	63850002202	1000 TABLET in 1 BOTTLE (63850-0022-2)Marketed from Oct 17, 2010

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Trihexyphenidyl Hydrochloride
Generic name (nonproprietary): trihexyphenidyl hydrochloride
Active ingredients: Trihexyphenidyl hydrochloride — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Natco Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091630
Marketing start: Oct 7, 2010
Listing expires: Dec 31, 2026
Identifiers: Product ID 63850-0022_2b77cfd6-ad8a-4cbf-a22c-eb69e7a8548cSPL ID 2b77cfd6-ad8a-4cbf-a22c-eb69e7a8548cSPL set ID b7e4200c-feff-4537-aad1-cf9989fd8c14RxCUI 905269, 905283UNII AO61G82577UPC 0363850002113, 0363850002229

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463850002201 followed by a unit qualifier and the quantity

Package 63850-0022-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 25, 2019.

Indications (excerpt from the label)

INDICATIONS AND USAGE Trihexyphenidyl HCl is indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic). It is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa. Additionally, it is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 091630

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091630
Product	Strength	Form · route	Labeler	Product NDC
Trihexyphenidyl Hydrochloride	Trihexyphenidyl hydrochloride 2 mg/1	TabletOral	Natco Pharma Limited	63850-0021
Trihexyphenidyl Hydrochloride	Trihexyphenidyl hydrochloride 2 mg/1	TabletOral	Bionpharma Inc.	69452-241